L. Nieuweboer‐Krobotová

Guidelines for the management of vitiligo: the European Dermatology Forum consensus

Agustı́n Alomar, Markus Böhm, Maria Lucia Dell’Anna et al. · British Journal of Dermatology · 2012 · 442 citations

Medicine, Dermatology, Pharmacotherapy +10

Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners

H.E. Teulings, Maarten Overkamp, Emel Ceylan et al. · British Journal of Dermatology · 2012 · 186 citations

Medicine, Dermatology, Oncology +17

Left-Right Comparison Study of the Combination of Fluticasone Propionate and UV-A vs Either Fluticasone Propionate or UV-A Alone for the Long-term Treatment of Vitiligo

W. Westerhof, L. Nieuweboer‐Krobotová, Paul Mulder et al. · Archives of Dermatology · 1999 · 110 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Linkage and association of HLA class II genes with vitiligo in a Dutch population

Mahdi Zamani, Marijke Spaepen, S.S. Sghar et al. · British Journal of Dermatology · 2001 · 92 citations

Life Sciences, Genetics, Immunology +17

Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study

Marije W. Kroon, Bas S. Wind, Johan F. Beek et al. · Journal of the American Academy of Dermatology · 2011 · 73 citations

Medicine, Dermatology, Ophthalmology +6